We are live on ! Find out more
DCI

Data Collective IV Portfolio holdings

AUM $55.9M
1-Year Est. Return 49.14%
This Fund
S&P 500
This Quarter Est. Return
-15.85%
1 Year Est. Return
+49.14%
3 Year Est. Return
+250.98%
5 Year Est. Return
10 Year Est. Return
AUM
$741M
AUM Growth
Cap. Flow
+$797M
Cap. Flow %
107.55%
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 74.67%
2 Healthcare 14.09%
3 Industrials 11.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMBK
1
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$553M 74.67%
+3,186,008
New +$582M
RXRX icon
2
Recursion Pharmaceuticals
RXRX
$1.62B
$102M 13.74%
+5,941,120
New +$112M
EVLV icon
3
Evolv Technologies
EVLV
$1.01B
$47.3M 6.38%
+10,601,281
New +$59.5M
RKLB icon
4
Rocket Lab Corp
RKLB
$39.9B
$36M 4.86%
+2,929,350
New +$40.2M
DFTX
5
Definium Therapeutics
DFTX
$5.57B
$2.6M 0.35%
+100,350
New +$3.2M

Similar funds

Data Collective IV's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Data Collective IV, which disclosed 5 positions worth $741M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Embark Technology, Inc. Common Stock: 3,186,008 shares worth $553M.

By sector, the portfolio is most concentrated in Technology at 75% of assets, followed by Healthcare and Industrials.

  • Data Collective IV's largest Q4 2021 buy was Embark Technology, Inc. Common Stock: 3,186,008 shares worth $553M.
  • Data Collective IV's ten largest holdings make up 100% of its $741M portfolio in Q4 2021.
  • Data Collective IV disclosed 5 positions in Q4 2021, its first 13F filing on record.

Based on Data Collective IV's 13F filing for Q4 2021, filed 14 Feb 2022.